Sign-off ledger
Every graded record names who read its papers against its letter. Some were read by the EBL editor, Arnold Sandlow, D.C. Others were read by a language model and are not yet reviewed by a clinician. Each record page says which, in its Sources section; this page lists all of them in one place, from the same files.
No record has yet been checked by a reviewer outside EBL. What each kind of check can and cannot show is set out on evidence integrity.
159 of 248 graded records read by the EBL editor. 89 read by a language model, not yet reviewed by a clinician.
No record has yet been checked by a reviewer outside EBL.
| Record | Kind | Read against the papers by | When | Outside review |
|---|---|---|---|---|
| 2-HOBA (2-Hydroxybenzylamine) | Supplement | The EBL editor | October 2026 | Not yet |
| 40Hz Gamma Sensory Stimulation | Device or therapy | The EBL editor | October 2026 | Not yet |
| 5-HTP (5-Hydroxytryptophan) | Supplement | A language model, not yet reviewed by a clinician | August 2026 | Not yet |
| Acarbose | Prescription | A language model, not yet reviewed by a clinician | September 2026 | Not yet |
| Acetyl-L-Carnitine (ALCAR) | Supplement | The EBL editor | October 2026 | Not yet |
| Adequate dietary protein (1.2 to 1.6 g/kg/day) | Protocol | The EBL editor | October 2026 | Not yet |
| Aerobic exercise (Zone 2) 150 min/week | Protocol | The EBL editor | October 2026 | Not yet |
| Aged garlic extract (480 mg/day for blood pressure; 2.4 g/day in plaque trials) | Protocol | The EBL editor | October 2026 | Not yet |
| Akkermansia muciniphila | Supplement | A language model, not yet reviewed by a clinician | August 2026 | Not yet |
| Alcohol reduction | Protocol | The EBL editor | October 2026 | Not yet |
| Alpha Lipoic Acid (ALA / R-ALA) | Supplement | The EBL editor | October 2026 | Not yet |
| Alpha-GPC (L-Alpha-Glycerylphosphorylcholine) | Supplement | A language model, not yet reviewed by a clinician | August 2026 | Not yet |
| Alpha-Lipoic Acid (racemic) 300–600 mg/day | Protocol | The EBL editor | October 2026 | Not yet |
| Amla (Indian Gooseberry, Emblica officinalis) | Supplement | The EBL editor | August 2026 | Not yet |
| Apigenin | Supplement | A language model, not yet reviewed by a clinician | August 2026 | Not yet |
| APOE genotype testing (learning your APOE result) | Protocol | A language model, not yet reviewed by a clinician | October 2026 | Not yet |
| Arterosil HP (Rhamnan Sulfate) | Supplement | A language model, not yet reviewed by a clinician | October 2026 | Not yet |
| Ashwagandha (standardized root extract) | Supplement | The EBL editor | October 2026 | Not yet |
| Ashwagandha standardized root extract 300 mg twice daily | Protocol | The EBL editor | August 2026 | Not yet |
| Aspirin (low-dose, primary prevention in healthy older adults) | Protocol | A language model, not yet reviewed by a clinician | August 2026 | Not yet |
| Astaxanthin | Supplement | The EBL editor | October 2026 | Not yet |
| Audiovisual / Brainwave Entrainment | Device or therapy | The EBL editor | August 2026 | Not yet |
| Avoiding ultra-processed food | Protocol | The EBL editor | October 2026 | Not yet |
| Bacopa monnieri standardized extract 300–450 mg/day | Protocol | The EBL editor | October 2026 | Not yet |
| Beetroot / Dietary Nitrate | Supplement | The EBL editor | October 2026 | Not yet |
| Benfotiamine | Supplement | A language model, not yet reviewed by a clinician | August 2026 | Not yet |
| Berberine 1.0 to 1.2 g/day (with meals) | Protocol | The EBL editor | October 2026 | Not yet |
| Berberine HCl | Supplement | The EBL editor | October 2026 | Not yet |
| Beta-Alanine | Supplement | The EBL editor | August 2026 | Not yet |
| Beta-Carotene (supplemental) | Supplement | A language model, not yet reviewed by a clinician | August 2026 | Not yet |
| Bitter Melon (Momordica charantia) | Supplement | A language model, not yet reviewed by a clinician | August 2026 | Not yet |
| Blood Flow Restriction Training | Device or therapy | The EBL editor | August 2026 | Not yet |
| Blood pressure lowering: treating high blood pressure and intensive targets | Protocol | A language model, not yet reviewed by a clinician | October 2026 | Not yet |
| Boron | Supplement | The EBL editor | October 2026 | Not yet |
| Boswellia + Celery Seed Extract (RestorCel) | Supplement | The EBL editor | September 2026 | Not yet |
| Boswellia serrata | Supplement | The EBL editor | August 2026 | Not yet |
| Bovine Colostrum | Supplement | The EBL editor | October 2026 | Not yet |
| BPC-157 (Body Protection Compound 157) | Supplement | A language model, not yet reviewed by a clinician | August 2026 | Not yet |
| Bright Light Therapy for Depression | Device or therapy | The EBL editor | October 2026 | Not yet |
| Bromelain | Supplement | The EBL editor | October 2026 | Not yet |
| C60 (Carbon-60 / Buckminsterfullerene) | Supplement | A language model, not yet reviewed by a clinician | October 2026 | Not yet |
| Calcium Alpha-Ketoglutarate (Ca-AKG) | Supplement | A language model, not yet reviewed by a clinician | October 2026 | Not yet |
| Caloric restriction (sustained ~25%) | Protocol | A language model, not yet reviewed by a clinician | August 2026 | Not yet |
| Carnosine | Supplement | A language model, not yet reviewed by a clinician | August 2026 | Not yet |
| Choline | Supplement | A language model, not yet reviewed by a clinician | August 2026 | Not yet |
| Chondroitin Sulfate | Supplement | The EBL editor | August 2026 | Not yet |
| Chromium (Picolinate) | Supplement | A language model, not yet reviewed by a clinician | August 2026 | Not yet |
| Cinnamon (Cassia / Ceylon) | Supplement | The EBL editor | August 2026 | Not yet |
| Citicoline (CDP-Choline) | Supplement | The EBL editor | October 2026 | Not yet |
| Coenzyme Q10 (CoQ10) | Supplement | The EBL editor | August 2026 | Not yet |
| Cold Water Immersion | Device or therapy | The EBL editor | October 2026 | Not yet |
| Collagen Peptides | Supplement | The EBL editor | October 2026 | Not yet |
| Concurrent training sequence: resistance before aerobic (same session) | Protocol | The EBL editor | October 2026 | Not yet |
| CoQ10 (ubiquinone) 300 mg/day | Protocol | The EBL editor | October 2026 | Not yet |
| Cordyceps (Cordyceps sinensis / militaris) | Supplement | A language model, not yet reviewed by a clinician | August 2026 | Not yet |
| CPAP for obstructive sleep apnea | Device or therapy | The EBL editor | October 2026 | Not yet |
| Creatine 3–5 g/day | Protocol | A language model, not yet reviewed by a clinician | August 2026 | Not yet |
| Creatine Monohydrate | Supplement | The EBL editor | October 2026 | Not yet |
| Curcumin (Turmeric Extract) | Supplement | The EBL editor | August 2026 | Not yet |
| Custom Foot Orthotics | Device or therapy | The EBL editor | September 2026 | Not yet |
| DASH dietary pattern | Protocol | The EBL editor | October 2026 | Not yet |
| Daytime napping (length and timing) | Protocol | The EBL editor | October 2026 | Not yet |
| DIM (Diindolylmethane) | Supplement | The EBL editor | October 2026 | Not yet |
| DMSO (Dimethyl Sulfoxide) | Supplement | The EBL editor | September 2026 | Not yet |
| EEG Neurofeedback | Device or therapy | The EBL editor | October 2026 | Not yet |
| EGCG (Epigallocatechin Gallate / Green Tea Extract) | Supplement | The EBL editor | October 2026 | Not yet |
| Ergothioneine (L-Ergothioneine) | Supplement | A language model, not yet reviewed by a clinician | October 2026 | Not yet |
| Evening warm bath or shower (40 to 42.5°C water) | Protocol | The EBL editor | October 2026 | Not yet |
| Exercise dose: how much weekly activity, from minutes a week to daily steps | Protocol | A language model, not yet reviewed by a clinician | October 2026 | Not yet |
| Exogenous Ketones (Ketone Esters and Salts) | Supplement | The EBL editor | October 2026 | Not yet |
| Exosome Therapy (extracellular vesicles) | Device or therapy | A language model, not yet reviewed by a clinician | October 2026 | Not yet |
| Extracorporeal Shockwave Therapy (ESWT) | Device or therapy | The EBL editor | October 2026 | Not yet |
| Fasting-mimicking diet (FMD, 5-day cycles) | Protocol | The EBL editor | October 2026 | Not yet |
| Fecal microbiota transplantation (FMT) | Protocol | The EBL editor | October 2026 | Not yet |
| Fenugreek (Trigonella foenum-graecum) | Supplement | The EBL editor | August 2026 | Not yet |
| Fisetin | Supplement | A language model, not yet reviewed by a clinician | October 2026 | Not yet |
| Folic Acid (supplemental, 1 mg/day) | Supplement | The EBL editor | October 2026 | Not yet |
| Fucoidan | Supplement | A language model, not yet reviewed by a clinician | August 2026 | Not yet |
| GABA (Gamma-Aminobutyric Acid) | Supplement | A language model, not yet reviewed by a clinician | August 2026 | Not yet |
| General health checks (multi-organ screening of asymptomatic adults) | Protocol | A language model, not yet reviewed by a clinician | August 2026 | Not yet |
| Genetic testing to choose diet or supplements (nutrigenomic panels) | Device or therapy | The EBL editor | October 2026 | Not yet |
| Geranylgeraniol (GG) | Supplement | A language model, not yet reviewed by a clinician | August 2026 | Not yet |
| Ginkgo Biloba (EGb 761) | Supplement | The EBL editor | August 2026 | Not yet |
| Glucosamine Sulfate | Supplement | A language model, not yet reviewed by a clinician | August 2026 | Not yet |
| Glutathione (Oral) | Supplement | The EBL editor | October 2026 | Not yet |
| Glycine | Supplement | The EBL editor | October 2026 | Not yet |
| GlyNAC (Glycine + N-Acetylcysteine) | Supplement | A language model, not yet reviewed by a clinician | August 2026 | Not yet |
| Gymnema sylvestre | Supplement | A language model, not yet reviewed by a clinician | August 2026 | Not yet |
| Hearing aids for age-related hearing loss | Device or therapy | The EBL editor | October 2026 | Not yet |
| Hearing aids with audiological counseling, for cognitive decline | Protocol | The EBL editor | October 2026 | Not yet |
| Hesperidin | Supplement | A language model, not yet reviewed by a clinician | August 2026 | Not yet |
| HMB (Beta-Hydroxy Beta-Methylbutyrate) | Supplement | The EBL editor | October 2026 | Not yet |
| Home blood pressure monitoring | Device or therapy | The EBL editor | August 2026 | Not yet |
| Hormone replacement therapy (combined estrogen + progestin, primary prevention) | Protocol | A language model, not yet reviewed by a clinician | August 2026 | Not yet |
| HPV testing for cervical cancer screening | Device or therapy | The EBL editor | October 2026 | Not yet |
| HRV Biofeedback | Device or therapy | The EBL editor | August 2026 | Not yet |
| Hyaluronic Acid (Oral) | Supplement | The EBL editor | October 2026 | Not yet |
| Hyperbaric Oxygen (HBOT) · 60 sessions at 2.0 ATA | Protocol | The EBL editor | October 2026 | Not yet |
| Hyperbaric Oxygen Therapy | Device or therapy | The EBL editor | October 2026 | Not yet |
| Hypoglossal nerve stimulation for obstructive sleep apnea | Device or therapy | The EBL editor | October 2026 | Not yet |
| Influenza vaccination (yearly flu shot), for older adults | Protocol | A language model, not yet reviewed by a clinician | November 2026 | Not yet |
| Infrared Sauna | Device or therapy | The EBL editor | October 2026 | Not yet |
| Inositol (Myo-inositol) | Supplement | The EBL editor | October 2026 | Not yet |
| Inspiratory Muscle Training | Device or therapy | The EBL editor | August 2026 | Not yet |
| Intermittent fasting (5:2 / alternate-day energy restriction) | Protocol | A language model, not yet reviewed by a clinician | August 2026 | Not yet |
| Isometric Handgrip Training | Device or therapy | The EBL editor | October 2026 | Not yet |
| Ketogenic diet (very-low-carbohydrate) | Protocol | The EBL editor | October 2026 | Not yet |
| L-Citrulline | Supplement | A language model, not yet reviewed by a clinician | August 2026 | Not yet |
| L-Theanine 200 mg/day | Protocol | The EBL editor | October 2026 | Not yet |
| L-Tyrosine | Supplement | A language model, not yet reviewed by a clinician | August 2026 | Not yet |
| Lactoferrin | Supplement | A language model, not yet reviewed by a clinician | October 2026 | Not yet |
| Lion's Mane 3 g/day fruiting-body powder (as studied) | Protocol | The EBL editor | October 2026 | Not yet |
| Lion's Mane Mushroom | Supplement | A language model, not yet reviewed by a clinician | August 2026 | Not yet |
| Lipids: lowering LDL cholesterol, and the contrast with raising HDL or lowering triglycerides | Protocol | A language model, not yet reviewed by a clinician | October 2026 | Not yet |
| Lithium (Low-Dose / Microdose) | Supplement | The EBL editor | October 2026 | Not yet |
| Low-dose CT screening for lung cancer in heavy smokers | Device or therapy | The EBL editor | October 2026 | Not yet |
| Low-Dose Naltrexone (LDN) | Prescription | A language model, not yet reviewed by a clinician | August 2026 | Not yet |
| Luteolin | Supplement | The EBL editor | October 2026 | Not yet |
| Magnesium | Supplement | The EBL editor | August 2026 | Not yet |
| Magnesium bisglycinate 250 mg elemental at bedtime | Protocol | A language model, not yet reviewed by a clinician | August 2026 | Not yet |
| Magnesium Glycinate 300–400 mg | Protocol | The EBL editor | October 2026 | Not yet |
| Magnesium Glycinate 300–400 mg elemental | Protocol | The EBL editor | October 2026 | Not yet |
| Mammography screening for breast cancer | Device or therapy | The EBL editor | October 2026 | Not yet |
| MBSR (Mindfulness-Based Stress Reduction) 8-week program | Protocol | The EBL editor | October 2026 | Not yet |
| Mediterranean diet + extra-virgin olive oil | Protocol | The EBL editor | August 2026 | Not yet |
| Melatonin | Supplement | The EBL editor | October 2026 | Not yet |
| Melatonin 0.3 to 0.5 mg (low dose), 30 to 60 minutes before bed | Protocol | The EBL editor | October 2026 | Not yet |
| Mesenchymal stem cell therapy (intravenous, allogeneic laromestrocel) | Device or therapy | A language model, not yet reviewed by a clinician | October 2026 | Not yet |
| Metformin (for longevity) | Prescription | A language model, not yet reviewed by a clinician | October 2026 | Not yet |
| Methylene Blue (low-dose) | Supplement | The EBL editor | October 2026 | Not yet |
| Milk Thistle (Silymarin) | Supplement | A language model, not yet reviewed by a clinician | August 2026 | Not yet |
| Mindfulness meditation for sleep (weekly group course with daily home practice) | Protocol | The EBL editor | October 2026 | Not yet |
| MitoQ (Mitoquinone Mesylate) | Supplement | The EBL editor | October 2026 | Not yet |
| Mobility and fall-prevention protocols | Protocol | The EBL editor | October 2026 | Not yet |
| Molecular Hydrogen (Inhaled) | Device or therapy | The EBL editor | October 2026 | Not yet |
| Molecular Hydrogen Water | Device or therapy | The EBL editor | October 2026 | Not yet |
| Montmorency Tart Cherry | Supplement | The EBL editor | October 2026 | Not yet |
| Morning bright light (light box or daylight) for sleep and the body clock | Protocol | A language model, not yet reviewed by a clinician | October 2026 | Not yet |
| Multi-cancer early detection blood test (cell-free DNA) | Device or therapy | A language model, not yet reviewed by a clinician | October 2026 | Not yet |
| Multi-domain diet and lifestyle program with supplements (8 weeks, as studied) | Protocol | A language model, not yet reviewed by a clinician | October 2026 | Not yet |
| Myofunctional therapy (mouth and throat exercises) for obstructive sleep apnea | Protocol | The EBL editor | October 2026 | Not yet |
| NAC (N-Acetyl Cysteine) | Supplement | The EBL editor | October 2026 | Not yet |
| NAD+ (Direct Oral Supplementation) | Supplement | A language model, not yet reviewed by a clinician | October 2026 | Not yet |
| Nasal valve (nasal EPAP) for obstructive sleep apnea | Device or therapy | The EBL editor | October 2026 | Not yet |
| Nattokinase | Supplement | The EBL editor | August 2026 | Not yet |
| Neuromuscular Electrical Stimulation (NMES) after Knee Replacement | Device or therapy | The EBL editor | October 2026 | Not yet |
| Niacin (extended-release, for lipids) | Supplement | A language model, not yet reviewed by a clinician | August 2026 | Not yet |
| NMN (Nicotinamide Mononucleotide) | Supplement | The EBL editor | October 2026 | Not yet |
| NMN 250–500 mg/day | Protocol | The EBL editor | September 2026 | Not yet |
| NR (Nicotinamide Riboside) | Supplement | The EBL editor | October 2026 | Not yet |
| Oat beta-glucan (3 g/day or more) for LDL-C | Protocol | The EBL editor | October 2026 | Not yet |
| Omega-3 DHA 1–2 g/day | Protocol | The EBL editor | October 2026 | Not yet |
| Omega-3 EPA/DHA 2 to 4 g/day (general supplementation) | Protocol | The EBL editor | October 2026 | Not yet |
| Omega-3. High-dose EPA (icosapent ethyl, 4 g) | Supplement | The EBL editor | October 2026 | Not yet |
| Oral appliance (mandibular advancement) for obstructive sleep apnea | Device or therapy | The EBL editor | October 2026 | Not yet |
| Padma Basic (Tibetan multi-herb formula) | Supplement | The EBL editor | August 2026 | Not yet |
| Panax Ginseng | Supplement | A language model, not yet reviewed by a clinician | August 2026 | Not yet |
| PectaSol Modified Citrus Pectin (MCP) | Supplement | The EBL editor | October 2026 | Not yet |
| PEMF (Pulsed Electromagnetic Field) for osteoarthritis symptoms | Protocol | A language model, not yet reviewed by a clinician | August 2026 | Not yet |
| Pentadecanoic Acid (C15:0, fatty15) | Supplement | The EBL editor | September 2026 | Not yet |
| Phosphatidylserine (PS) | Supplement | A language model, not yet reviewed by a clinician | August 2026 | Not yet |
| Phosphatidylserine 300 mg/day (soy-derived) | Protocol | The EBL editor | October 2026 | Not yet |
| Photobiomodulation (musculoskeletal) | Device or therapy | The EBL editor | August 2026 | Not yet |
| Photobiomodulation to Prevent Oral Mucositis | Device or therapy | The EBL editor | September 2026 | Not yet |
| Piperlongumine | Supplement | A language model, not yet reviewed by a clinician | August 2026 | Not yet |
| Plant sterols or stanols 1.6 to 2 g/day | Protocol | The EBL editor | August 2026 | Not yet |
| Pneumatic Compression (sequential) | Protocol | The EBL editor | August 2026 | Not yet |
| Pneumatic Lymphatic Compression | Device or therapy | The EBL editor | August 2026 | Not yet |
| Pneumococcal vaccination (pneumonia vaccines), for older adults | Protocol | A language model, not yet reviewed by a clinician | November 2026 | Not yet |
| Positional therapy for position-dependent sleep apnea | Device or therapy | The EBL editor | October 2026 | Not yet |
| Power (high-velocity) resistance training versus traditional strength training | Protocol | A language model, not yet reviewed by a clinician | August 2026 | Not yet |
| PQQ (Pyrroloquinoline Quinone) | Supplement | A language model, not yet reviewed by a clinician | August 2026 | Not yet |
| Probiotics | Supplement | The EBL editor | October 2026 | Not yet |
| Procyanidin C1 (PCC1) | Supplement | A language model, not yet reviewed by a clinician | August 2026 | Not yet |
| PSA screening for prostate cancer | Device or therapy | The EBL editor | October 2026 | Not yet |
| Psyllium husk (10 to 15 g/day) for LDL-C | Protocol | The EBL editor | October 2026 | Not yet |
| Pterostilbene | Supplement | The EBL editor | October 2026 | Not yet |
| Pulsed Electromagnetic Field (PEMF) | Device or therapy | A language model, not yet reviewed by a clinician | August 2026 | Not yet |
| Purpose in life: meaning-centered therapy, purpose programs and volunteering | Protocol | A language model, not yet reviewed by a clinician | October 2026 | Not yet |
| Quercetin | Supplement | The EBL editor | October 2026 | Not yet |
| Quitting smoking: programs and medicines | Protocol | The EBL editor | October 2026 | Not yet |
| Rapamycin (Sirolimus) | Prescription | A language model, not yet reviewed by a clinician | August 2026 | Not yet |
| Red Light / Near-Infrared (630–850nm) | Protocol | The EBL editor | October 2026 | Not yet |
| Red Yeast Rice (Monacolin K) | Supplement | A language model, not yet reviewed by a clinician | September 2026 | Not yet |
| Reducing anticholinergic drug burden | Protocol | The EBL editor | October 2026 | Not yet |
| Regular blood donation (iron reduction) | Protocol | The EBL editor | October 2026 | Not yet |
| REHIT / Sprint Interval Training | Device or therapy | The EBL editor | August 2026 | Not yet |
| Reishi (Ganoderma lucidum) | Supplement | The EBL editor | October 2026 | Not yet |
| Resistance training 2–3×/week | Protocol | The EBL editor | October 2026 | Not yet |
| Resveratrol (Trans-Resveratrol) | Supplement | The EBL editor | October 2026 | Not yet |
| Retatrutide | Prescription | The EBL editor | October 2026 | Not yet |
| Rhodiola Rosea | Supplement | A language model, not yet reviewed by a clinician | August 2026 | Not yet |
| RIMSO-50 (Dimethyl Sulfoxide Bladder Instillation) | Prescription | The EBL editor | September 2026 | Not yet |
| RSV vaccination (respiratory syncytial virus), for older adults | Protocol | A language model, not yet reviewed by a clinician | November 2026 | Not yet |
| Saffron (Crocus sativus) | Supplement | The EBL editor | October 2026 | Not yet |
| SAM-e (S-adenosyl-L-methionine) | Supplement | The EBL editor | October 2026 | Not yet |
| Seed oils: linoleic-acid vegetable oils in place of saturated fat | Protocol | A language model, not yet reviewed by a clinician | October 2026 | Not yet |
| Selenium (Selenomethionine) | Supplement | The EBL editor | October 2026 | Not yet |
| Semaglutide | Prescription | The EBL editor | October 2026 | Not yet |
| Sermorelin (GHRH 1-29) | Supplement | The EBL editor | October 2026 | Not yet |
| Serrapeptase (Serratiopeptidase) | Supplement | The EBL editor | October 2026 | Not yet |
| SGLT2 inhibitors (empagliflozin, dapagliflozin) | Prescription | The EBL editor | October 2026 | Not yet |
| Shingles vaccination (recombinant zoster vaccine), for shingles and dementia | Protocol | The EBL editor | October 2026 | Not yet |
| Sigmoidoscopy and colonoscopy screening for colorectal cancer | Device or therapy | The EBL editor | October 2026 | Not yet |
| Sleep duration & quality (as longevity target) | Device or therapy | The EBL editor | August 2026 | Not yet |
| Sleep restriction treatment (CBT-I) | Protocol | The EBL editor | August 2026 | Not yet |
| Social connection programs for loneliness in older adults | Protocol | A language model, not yet reviewed by a clinician | October 2026 | Not yet |
| Sodium reduction to under 2,300 mg/day | Protocol | The EBL editor | October 2026 | Not yet |
| Spermidine | Supplement | A language model, not yet reviewed by a clinician | October 2026 | Not yet |
| Statins (simvastatin, pravastatin, atorvastatin, rosuvastatin) | Prescription | A language model, not yet reviewed by a clinician | October 2026 | Not yet |
| Steam Inhalation (for colds and sinus symptoms) | Device or therapy | A language model, not yet reviewed by a clinician | October 2026 | Not yet |
| Steam Room (steam bath, hammam) | Device or therapy | A language model, not yet reviewed by a clinician | October 2026 | Not yet |
| Stool-based colorectal screening (gFOBT and FIT) | Device or therapy | The EBL editor | October 2026 | Not yet |
| Structured exercise program after treatment for non-metastatic cancer | Protocol | The EBL editor | October 2026 | Not yet |
| Sulforaphane (Broccoli Sprout Extract) | Supplement | A language model, not yet reviewed by a clinician | August 2026 | Not yet |
| Sun and skin: daily sunscreen, sun protection and oral nicotinamide | Protocol | A language model, not yet reviewed by a clinician | October 2026 | Not yet |
| Taurine | Supplement | The EBL editor | October 2026 | Not yet |
| Teeth and gums: periodontal treatment and daily oral hygiene | Protocol | A language model, not yet reviewed by a clinician | October 2026 | Not yet |
| Therapeutic plasma exchange (plasmapheresis for aging) | Device or therapy | A language model, not yet reviewed by a clinician | August 2026 | Not yet |
| Therapeutic Ultrasound | Device or therapy | A language model, not yet reviewed by a clinician | August 2026 | Not yet |
| Time-restricted eating (early, 6 to 10 hour window) | Protocol | The EBL editor | October 2026 | Not yet |
| Tirzepatide | Prescription | The EBL editor | October 2026 | Not yet |
| TMG (Trimethylglycine / Betaine) | Supplement | A language model, not yet reviewed by a clinician | October 2026 | Not yet |
| Tongkat Ali (Eurycoma longifolia) | Supplement | A language model, not yet reviewed by a clinician | August 2026 | Not yet |
| Traditional Finnish Sauna (dry sauna) | Device or therapy | A language model, not yet reviewed by a clinician | October 2026 | Not yet |
| Transcendental Meditation (TM) · secondary CVD prevention | Protocol | The EBL editor | October 2026 | Not yet |
| Transcranial Direct Current Stimulation | Device or therapy | A language model, not yet reviewed by a clinician | August 2026 | Not yet |
| Transcranial Magnetic Stimulation (TMS) for Depression | Device or therapy | The EBL editor | October 2026 | Not yet |
| Transcranial Photobiomodulation | Device or therapy | A language model, not yet reviewed by a clinician | August 2026 | Not yet |
| Transcutaneous Vagus Nerve Stimulation | Device or therapy | The EBL editor | October 2026 | Not yet |
| Trehalose | Supplement | A language model, not yet reviewed by a clinician | August 2026 | Not yet |
| Turkey Tail (Trametes versicolor / PSK) | Supplement | A language model, not yet reviewed by a clinician | August 2026 | Not yet |
| Urolithin A | Supplement | A language model, not yet reviewed by a clinician | October 2026 | Not yet |
| Vascanox HP (Nitric Oxide / Noxa24) | Supplement | A language model, not yet reviewed by a clinician | August 2026 | Not yet |
| Vision and cataract surgery: eyesight, falls and glasses | Protocol | A language model, not yet reviewed by a clinician | October 2026 | Not yet |
| Vitamin C (ascorbic acid) | Supplement | The EBL editor | October 2026 | Not yet |
| Vitamin D3 | Supplement | The EBL editor | October 2026 | Not yet |
| Vitamin D3 2,000–4,000 IU + K2 MK-7 100 mcg | Protocol | The EBL editor | October 2026 | Not yet |
| Vitamin E (supplemental alpha-tocopherol) | Supplement | A language model, not yet reviewed by a clinician | August 2026 | Not yet |
| Vitamin K2 (MK-7 / Menaquinone-7) | Supplement | The EBL editor | October 2026 | Not yet |
| VO₂max training (Zone 2 + intervals) | Protocol | The EBL editor | October 2026 | Not yet |
| Weekly vigorous exercise volume compressed into one session (weekend warrior pattern) | Protocol | A language model, not yet reviewed by a clinician | August 2026 | Not yet |
| WGP Beta-1,3/1,6-D-Glucan | Supplement | The EBL editor | October 2026 | Not yet |
| Whole Body Vibration | Device or therapy | The EBL editor | August 2026 | Not yet |
| Whole-body MRI screening (asymptomatic adults) | Device or therapy | A language model, not yet reviewed by a clinician | August 2026 | Not yet |
| Whole-food plant-based diet | Protocol | The EBL editor | October 2026 | Not yet |
| Zinc | Supplement | The EBL editor | August 2026 | Not yet |
| Zone 2 aerobic training | Device or therapy | The EBL editor | October 2026 | Not yet |